Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

H. Lundbeck (US non-core product portfolio)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Portfolio of central nervous system products. The portfolio comprises rights to the non-core pharmaceutical products and drugs which addresses psychiatric and neurological disorders.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • United States

H. Lundbeck (US non-core product portfolio) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore H. Lundbeck (US non-core product portfolio)‘s full profile, request access.

Request full access to PitchBook

H. Lundbeck (US non-core product portfolio) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore H. Lundbeck (US non-core product portfolio)‘s full profile, request access.

Request full access to PitchBook